Abstract
BACKGROUND--Circulating immune complexes can be elevated in serum samples of patients with sarcoidosis and are associated with disease activity, but their diagnostic significance is not understood. METHODS--The different classes of circulating immune complexes containing immunoglobulin A, G, or M, and the content of complement in circulating immune complexes (polyethylene glycol precipitation) as well as levels of complement binding circulating immune complexes (complement binding assay) were determined in 19 patients with active, untreated pulmonary sarcoidosis. The results were compared with other parameters in the serum (soluble interleukin 2 receptor, angiotensin converting enzyme, immunoglobulin A, G, and M) and the bronchoalveolar lavage fluid (lymphocytes, helper cells, suppressor cells, activated T cells), and with radiological stage and functional parameters (FEV1, vital capacity, total lung capacity, transfer coefficient (KCO), and the alveolar-arterial oxygen difference during exercise). RESULTS--In all patients circulating immune complexes could be detected by polyethylene glycol precipitation and were similar to control subjects. The content of C1q in circulating immune complexes was higher than in controls, yet in all but one of the cases was still within normal limits. In contrast, elevated levels of complement binding circulating immune complexes were found in 67% of the patients. No correlation was seen between circulating immune complexes and any of the other parameters in the serum, bronchoalveolar lavage fluid, or lung function values. No differences were found between radiological type I and II presentations of sarcoidosis. CONCLUSIONS--The complement binding assay showed a much higher sensitivity for the detection of circulating immune complexes in active pulmonary sarcoidosis than the polyethylene glycol precipitation method. As there was no correlation between levels of circulating immune complexes and other parameters of the disease they are probably not useful for the assessment of disease activity.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gilliland B. C. Serum sickness and immune complexes. N Engl J Med. 1984 Nov 29;311(22):1435–1436. doi: 10.1056/NEJM198411293112210. [DOI] [PubMed] [Google Scholar]
- Hunninghake G. W., Crystal R. G. Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes. J Clin Invest. 1981 Jan;67(1):86–92. doi: 10.1172/JCI110036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Krapf F., Renger D., Schedel I., Leiendecker K., Leyssens H., Deicher H. A PEG-precipitation laser nephelometer technique for detection and characterization of circulating immune complexes in human sera. J Immunol Methods. 1982 Oct 15;54(1):107–117. doi: 10.1016/0022-1759(82)90119-3. [DOI] [PubMed] [Google Scholar]
- Müller-Quernheim J., Pfeifer S., Strausz J., Ferlinz R. Correlation of clinical and immunologic parameters of the inflammatory activity of pulmonary sarcoidosis. Am Rev Respir Dis. 1991 Dec;144(6):1322–1329. doi: 10.1164/ajrccm/144.6.1322. [DOI] [PubMed] [Google Scholar]
- Rooney D. P., Finch M. B., Elborn J. S., Stanford C. F. Circulating immune complexes in sarcoidosis, a clinical role for the Raji assay? Eur Respir J. 1990 Jul;3(7):760–764. [PubMed] [Google Scholar]
- Saint-Remy J. R., Mitchell D. N., Cole P. J. Variation in immunoglobulin levels and circulating immune complexes in sarcoidosis. Correlation with extent of disease and duration of symptoms. Am Rev Respir Dis. 1983 Jan;127(1):23–27. doi: 10.1164/arrd.1983.127.1.23. [DOI] [PubMed] [Google Scholar]
- Thomas P. D., Hunninghake G. W. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis. 1987 Mar;135(3):747–760. doi: 10.1164/arrd.1987.135.3.747. [DOI] [PubMed] [Google Scholar]
- Zubler R. H., Lange G., Lambert P. H., Miescher P. A. Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus. J Immunol. 1976 Jan;116(1):232–235. [PubMed] [Google Scholar]